Werewolf Therapeutics, Inc. (HOWL)
NASDAQ · Manufacturing · Pharmaceutical preparations
$0.9599−$0.0211 (−2.15%) on the dayAs of the close; data may be delayed.
HOWL price, last 12 months
Key stats
- Previous close
- $0.9810
- Open
- $0.9750
- Day range
- $0.9599 – $0.9826
- 52-week range
- $0.2700 – $2.38
- Volume
- 454.9K
- Avg volume (20 days)
- 902.8K
- Market cap
- $46.7M
Performance
1W−0.5%
1M−2.9%
3M+197.2%
6M+11.2%
YTD+51.5%
1Y−53.7%
vs S&P 500, 1Y−70.5 pts
Technicals and fundamentals
About Werewolf Therapeutics, Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $46.7M